Pneumococcal Vaccines Market Size, Share & Industry Analysis, By Product Type (PCV13, PCV15, PCV20, PCV21, PPSV23, and Others), By Age Group (Pediatric and Adults), By Distribution Channel (Hospital & Retail Pharmacies, Government Suppliers, and Others), and Regional Forecast, 2026-2034

Last Updated: January 19, 2026 | Format: PDF | Report ID: FBI113672

We will customize the report to meet your research goals, helping you gain a competitive edge, and make informed decisions.

Schedule a 30 minutes session to understand our consulting capabilities – SCHEDULE NOW

Table of Content

Introduction
1. Research Scope
2. Market Segmentation
3. Research Methodology
4. Definitions and Assumptions
Executive Summary
Market Dynamics
1. Market Drivers
2. Market Restraints
3. Market Opportunities
4. Market Trends
Key Insights
1. Regulatory Scenarios, By Key Countries/Regions
2. Vaccination Coverage- By Key Countries/ Regions
3. Government Immunization Programs for Pneumococcal Vaccines- By Key Countries/ Regions
4. Technological Advancements in Polio Vaccines Market
5. Key Industry Developments (Mergers, Acquisitions, Partnerships, Launches, etc.)
Global Pneumococcal Vaccines Market Analysis, Insights and Forecast, 2021-2034
1. Market Analysis, Insights and Forecast – By Product Type
  1. PCV13
  2. PCV15
  3. PCV20
  4. PCV21
  5. PPSV23
  6. Others
2. Market Analysis, Insights and Forecast – By Age Group
  1. Pediatric
  2. Adults
3. Market Analysis, Insights and Forecast – By Distribution Channel
  1. Hospital & Retail Pharmacies
  2. Government Suppliers
  3. Others
4. Market Analysis, Insights and Forecast – Region
  1. North America
  2. Europe
  3. Asia Pacific
  4. Latin America
  5. Middle East & Africa
North America Pneumococcal Vaccines Market Analysis, Insights and Forecast, 2021-2034
1. Market Analysis, Insights and Forecast – By Product Type
  1. PCV13
  2. PCV15
  3. PCV20
  4. PCV21
  5. PPSV23
  6. Others
2. Market Analysis, Insights and Forecast – By Age Group
  1. Pediatric
  2. Adults
3. Market Analysis, Insights and Forecast – By Distribution Channel
  1. Hospital & Retail Pharmacies
  2. Government Suppliers
  3. Others
4. Market Analysis, Insights and Forecast – By Country
  1. U.S.
  2. Canada
Europe Pneumococcal Vaccines Market Analysis, Insights and Forecast, 2021-2034
1. Market Analysis, Insights and Forecast – By Product Type
  1. PCV13
  2. PCV15
  3. PCV20
  4. PCV21
  5. PPSV23
  6. Others
2. Market Analysis, Insights and Forecast – By Age Group
  1. Pediatric
  2. Adults
3. Market Analysis, Insights and Forecast – By Distribution Channel
  1. Hospital & Retail Pharmacies
  2. Government Suppliers
  3. Others
4. Market Analysis, Insights and Forecast – By Country/Sub-Region
  1. Germany
  2. U.K.
  3. France
  4. Italy
  5. Spain
  6. Scandinavia
  7. Rest of Europe
Asia Pacific Pneumococcal Vaccines Market Analysis, Insights and Forecast, 2021-2034
1. Market Analysis, Insights and Forecast – By Product Type
  1. PCV13
  2. PCV15
  3. PCV20
  4. PCV21
  5. PPSV23
  6. Others
2. Market Analysis, Insights and Forecast – By Age Group
  1. Pediatric
  2. Adults
3. Market Analysis, Insights and Forecast – By Distribution Channel
  1. Hospital & Retail Pharmacies
  2. Government Suppliers
  3. Others
4. Market Analysis, Insights and Forecast – By Country/Sub-Region
  1. China
  2. Japan
  3. India
  4. Australia
  5. Southeast Asia
  6. Rest of Asia Pacific
Latin America Pneumococcal Vaccines Market Analysis, Insights and Forecast, 2021-2034
1. Market Analysis, Insights and Forecast – By Product Type
  1. PCV13
  2. PCV15
  3. PCV20
  4. PCV21
  5. PPSV23
  6. Others
2. Market Analysis, Insights and Forecast – By Age Group
  1. Pediatric
  2. Adults
3. Market Analysis, Insights and Forecast – By Distribution Channel
  1. Hospital & Retail Pharmacies
  2. Government Suppliers
  3. Others
4. Market Analysis, Insights and Forecast – By Country/Sub-Region
  1. Brazil
  2. Mexico
  3. Rest of Latin America
Middle East & Africa Pneumococcal Vaccines Market Analysis, Insights and Forecast, 2021-2034
1. Market Analysis, Insights and Forecast – By Product Type
  1. PCV13
  2. PCV15
  3. PCV20
  4. PCV21
  5. PPSV23
  6. Others
2. Market Analysis, Insights and Forecast – By Age Group
  1. Pediatric
  2. Adults
3. Market Analysis, Insights and Forecast – By Distribution Channel
  1. Hospital & Retail Pharmacies
  2. Government Suppliers
  3. Others
4. Market Analysis, Insights and Forecast – By Country/Sub-Region
  1. GCC
  2. South Africa
  3. Rest of Middle East & Africa
Competitive Analysis
1. Global Market Share Analysis (2025)
2. Company Profiles
  1. GSK plc.
    1. Overview
    2. Products Types
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. Financials (Based on Availability)
  2. Merck & Co., Inc.
    1. Overview
    2. Products Types
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. Financials (Based on Availability)
  3. Abbott
    1. Overview
    2. Products Types
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. Financials (Based on Availability)
  4. Sanofi
    1. Overview
    2. Products Types
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. Financials (Based on Availability)
  5. Pfizer
    1. Overview
    2. Products Types
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. Financials (Based on Availability)
  6. Inventprise
    1. Overview
    2. Products Types
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. Financials (Based on Availability)
  7. Vaxcyte
    1. Overview
    2. Products Types
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. Financials (Based on Availability)
  8. Walvax Biotechnology Co., Ltd.
    1. Overview
    2. Products Types
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. Financials (Based on Availability)
  9. SK Bioscience
    1. Overview
    2. Products Types
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. Financials (Based on Availability)

Introduction
1. Research Scope
2. Market Segmentation
3. Research Methodology
4. Definitions and Assumptions
Executive Summary
Market Dynamics
1. Market Drivers
2. Market Restraints
3. Market Opportunities
4. Market Trends
Key Insights
1. Regulatory Scenarios, By Key Countries/Regions
2. Vaccination Coverage- By Key Countries/ Regions
3. Government Immunization Programs for Pneumococcal Vaccines- By Key Countries/ Regions
4. Technological Advancements in Polio Vaccines Market
5. Key Industry Developments (Mergers, Acquisitions, Partnerships, Launches, etc.)
Global Pneumococcal Vaccines Market Analysis, Insights and Forecast, 2021-2034
1. Market Analysis, Insights and Forecast – By Product Type
  1. PCV13
  2. PCV15
  3. PCV20
  4. PCV21
  5. PPSV23
  6. Others
2. Market Analysis, Insights and Forecast – By Age Group
  1. Pediatric
  2. Adults
3. Market Analysis, Insights and Forecast – By Distribution Channel
  1. Hospital & Retail Pharmacies
  2. Government Suppliers
  3. Others
4. Market Analysis, Insights and Forecast – Region
  1. North America
  2. Europe
  3. Asia Pacific
  4. Latin America
  5. Middle East & Africa
North America Pneumococcal Vaccines Market Analysis, Insights and Forecast, 2021-2034
1. Market Analysis, Insights and Forecast – By Product Type
  1. PCV13
  2. PCV15
  3. PCV20
  4. PCV21
  5. PPSV23
  6. Others
2. Market Analysis, Insights and Forecast – By Age Group
  1. Pediatric
  2. Adults
3. Market Analysis, Insights and Forecast – By Distribution Channel
  1. Hospital & Retail Pharmacies
  2. Government Suppliers
  3. Others
4. Market Analysis, Insights and Forecast – By Country
  1. U.S.
  2. Canada
Europe Pneumococcal Vaccines Market Analysis, Insights and Forecast, 2021-2034
1. Market Analysis, Insights and Forecast – By Product Type
  1. PCV13
  2. PCV15
  3. PCV20
  4. PCV21
  5. PPSV23
  6. Others
2. Market Analysis, Insights and Forecast – By Age Group
  1. Pediatric
  2. Adults
3. Market Analysis, Insights and Forecast – By Distribution Channel
  1. Hospital & Retail Pharmacies
  2. Government Suppliers
  3. Others
4. Market Analysis, Insights and Forecast – By Country/Sub-Region
  1. Germany
  2. U.K.
  3. France
  4. Italy
  5. Spain
  6. Scandinavia
  7. Rest of Europe
Asia Pacific Pneumococcal Vaccines Market Analysis, Insights and Forecast, 2021-2034
1. Market Analysis, Insights and Forecast – By Product Type
  1. PCV13
  2. PCV15
  3. PCV20
  4. PCV21
  5. PPSV23
  6. Others
2. Market Analysis, Insights and Forecast – By Age Group
  1. Pediatric
  2. Adults
3. Market Analysis, Insights and Forecast – By Distribution Channel
  1. Hospital & Retail Pharmacies
  2. Government Suppliers
  3. Others
4. Market Analysis, Insights and Forecast – By Country/Sub-Region
  1. China
  2. Japan
  3. India
  4. Australia
  5. Southeast Asia
  6. Rest of Asia Pacific
Latin America Pneumococcal Vaccines Market Analysis, Insights and Forecast, 2021-2034
1. Market Analysis, Insights and Forecast – By Product Type
  1. PCV13
  2. PCV15
  3. PCV20
  4. PCV21
  5. PPSV23
  6. Others
2. Market Analysis, Insights and Forecast – By Age Group
  1. Pediatric
  2. Adults
3. Market Analysis, Insights and Forecast – By Distribution Channel
  1. Hospital & Retail Pharmacies
  2. Government Suppliers
  3. Others
4. Market Analysis, Insights and Forecast – By Country/Sub-Region
  1. Brazil
  2. Mexico
  3. Rest of Latin America
Middle East & Africa Pneumococcal Vaccines Market Analysis, Insights and Forecast, 2021-2034
1. Market Analysis, Insights and Forecast – By Product Type
  1. PCV13
  2. PCV15
  3. PCV20
  4. PCV21
  5. PPSV23
  6. Others
2. Market Analysis, Insights and Forecast – By Age Group
  1. Pediatric
  2. Adults
3. Market Analysis, Insights and Forecast – By Distribution Channel
  1. Hospital & Retail Pharmacies
  2. Government Suppliers
  3. Others
4. Market Analysis, Insights and Forecast – By Country/Sub-Region
  1. GCC
  2. South Africa
  3. Rest of Middle East & Africa
Competitive Analysis
1. Global Market Share Analysis (2025)
2. Company Profiles
  1. GSK plc.
    1. Overview
    2. Products Types
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. Financials (Based on Availability)
  2. Merck & Co., Inc.
    1. Overview
    2. Products Types
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. Financials (Based on Availability)
  3. Abbott
    1. Overview
    2. Products Types
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. Financials (Based on Availability)
  4. Sanofi
    1. Overview
    2. Products Types
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. Financials (Based on Availability)
  5. Pfizer
    1. Overview
    2. Products Types
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. Financials (Based on Availability)
  6. Inventprise
    1. Overview
    2. Products Types
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. Financials (Based on Availability)
  7. Vaxcyte
    1. Overview
    2. Products Types
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. Financials (Based on Availability)
  8. Walvax Biotechnology Co., Ltd.
    1. Overview
    2. Products Types
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. Financials (Based on Availability)
  9. SK Bioscience
    1. Overview
    2. Products Types
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. Financials (Based on Availability)

Read Less

List of Figures

Figure 1: Global Pneumococcal Vaccines Market Revenue Breakdown (USD billion, %) by Region, 2025 & 2034

Figure 2: Global Pneumococcal Vaccines Market Value Share (%), by Product Type, 2025 & 2034

Figure 3: Global Pneumococcal Vaccines Market Value Share (%), by Age Group, 2025 & 2034

Figure 4: Global Pneumococcal Vaccines Market Value Share (%), by Distribution Channel, 2025 & 2034

Figure 5: Global Pneumococcal Vaccines Market Value Share (%), by Region, 2025 & 2034

Figure 6: North America Pneumococcal Vaccines Market Value (USD billion), by Product Type, 2025 & 2034

Figure 7: North America Pneumococcal Vaccines Market Value Share (%), by Product Type, 2025

Figure 8: North America Pneumococcal Vaccines Market Value (USD billion), by Age Group, 2025 & 2034

Figure 9: North America Pneumococcal Vaccines Market Value Share (%), by Age Group, 2025

Figure 10: North America Pneumococcal Vaccines Market Value (USD billion), by Distribution Channel, 2025 & 2034

Figure 11: North America Pneumococcal Vaccines Market Value Share (%), by Distribution Channel, 2025

Figure 12: North America Pneumococcal Vaccines Market Value (USD billion), by Country, 2025 & 2034

Figure 13: North America Pneumococcal Vaccines Market Value Share (%), by Country, 2025

Figure 14: Europe Pneumococcal Vaccines Market Value (USD billion), by Product Type, 2025 & 2034

Figure 15: Europe Pneumococcal Vaccines Market Value Share (%), by Product Type, 2025

Figure 16: Europe Pneumococcal Vaccines Market Value (USD billion), by Age Group, 2025 & 2034

Figure 17: Europe Pneumococcal Vaccines Market Value Share (%), by Age Group, 2025

Figure 18: Europe Pneumococcal Vaccines Market Value (USD billion), by Distribution Channel, 2025 & 2034

Figure 19: Europe Pneumococcal Vaccines Market Value Share (%), by Distribution Channel, 2025

Figure 20: Europe Pneumococcal Vaccines Market Value (USD billion), by Country/Sub-Region, 2025 & 2034

Figure 21: Europe Pneumococcal Vaccines Market Value Share (%), by Country/Sub-Region, 2025

Figure 22: Asia Pacific Pneumococcal Vaccines Market Value (USD billion), by Product Type, 2025 & 2034

Figure 23: Asia Pacific Pneumococcal Vaccines Market Value Share (%), by Product Type, 2025

Figure 24: Asia Pacific Pneumococcal Vaccines Market Value (USD billion), by Age Group, 2025 & 2034

Figure 25: Asia Pacific Pneumococcal Vaccines Market Value Share (%), by Age Group, 2025

Figure 26: Asia Pacific Pneumococcal Vaccines Market Value (USD billion), by Distribution Channel, 2025 & 2034

Figure 27: Asia Pacific Pneumococcal Vaccines Market Value Share (%), by Distribution Channel, 2025

Figure 28: Asia Pacific Pneumococcal Vaccines Market Value (USD billion), by Country/Sub-Region, 2025 & 2034

Figure 29: Asia Pacific Pneumococcal Vaccines Market Value Share (%), by Country/Sub-Region, 2025

Figure 30: Latin America Pneumococcal Vaccines Market Value (USD billion), by Product Type, 2025 & 2034

Figure 31: Latin America Pneumococcal Vaccines Market Value Share (%), by Product Type, 2025

Figure 32: Latin America Pneumococcal Vaccines Market Value (USD billion), by Age Group, 2025 & 2034

Figure 33: Latin America Pneumococcal Vaccines Market Value Share (%), by Age Group, 2025

Figure 34: Latin America Pneumococcal Vaccines Market Value (USD billion), by Distribution Channel, 2025 & 2034

Figure 35: Latin America Pneumococcal Vaccines Market Value Share (%), by Distribution Channel, 2025

Figure 36: Latin America Pneumococcal Vaccines Market Value (USD billion), by Country/Sub-Region, 2025 & 2034

Figure 37: Latin America Pneumococcal Vaccines Market Value Share (%), by Country/Sub-Region, 2025

Figure 38: Middle East & Africa Pneumococcal Vaccines Market Value (USD billion), by Product Type, 2025 & 2034

Figure 39: Middle East & Africa Pneumococcal Vaccines Market Value Share (%), by Product Type, 2025

Figure 40: Middle East & Africa Pneumococcal Vaccines Market Value (USD billion), by Age Group, 2025 & 2034

Figure 41: Middle East & Africa Pneumococcal Vaccines Market Value Share (%), by Age Group, 2025

Figure 42: Middle East & Africa Pneumococcal Vaccines Market Value (USD billion), by Distribution Channel, 2025 & 2034

Figure 43: Middle East & Africa Pneumococcal Vaccines Market Value Share (%), by Distribution Channel, 2025

Figure 44: Middle East & Africa Pneumococcal Vaccines Market Value (USD billion), by Country/Sub-Region, 2025 & 2034

Figure 45: Middle East & Africa Pneumococcal Vaccines Market Value Share (%), by Country/Sub-Region, 2025

Figure 46: Global Pneumococcal Vaccines Market Share (%), by Company, 2025

List of Tables

Table 1: Global Pneumococcal Vaccines Market Revenue (USD billion) Forecast, by Product Type, 2021–2034

Table 2: Global Pneumococcal Vaccines Market Revenue (USD billion) Forecast, by Age Group, 2021–2034

Table 3: Global Pneumococcal Vaccines Market Revenue (USD billion) Forecast, by Distribution Channel, 2021–2034

Table 4: Global Pneumococcal Vaccines Market Revenue (USD billion) Forecast, by Region, 2021-2034

Table 5: North America Pneumococcal Vaccines Market Revenue (USD billion) Forecast, by Product Type, 2021–2034

Table 6: North America Pneumococcal Vaccines Market Revenue (USD billion) Forecast, by Age Group, 2021–2034

Table 7: North America Pneumococcal Vaccines Market Revenue (USD billion) Forecast, by Distribution Channel, 2021–2034

Table 8: North America Pneumococcal Vaccines Market Revenue (USD billion) Forecast, by Country, 2021-2034

Table 9: Europe Pneumococcal Vaccines Market Revenue (USD billion) Forecast, by Product Type, 2021–2034

Table 10: Europe Pneumococcal Vaccines Market Revenue (USD billion) Forecast, by Age Group, 2021–2034

Table 11: Europe Pneumococcal Vaccines Market Revenue (USD billion) Forecast, by Distribution Channel, 2021–2034

Table 12: Europe Pneumococcal Vaccines Market Revenue (USD billion) Forecast, by Country/Sub-Region, 2021-2034

Table 13: Asia Pacific Pneumococcal Vaccines Market Revenue (USD billion) Forecast, by Product Type, 2021–2034

Table 14: Asia Pacific Pneumococcal Vaccines Market Revenue (USD billion) Forecast, by Age Group, 2021–2034

Table 15: Asia Pacific Pneumococcal Vaccines Market Revenue (USD billion) Forecast, by Distribution Channel, 2021–2034

Table 16: Asia Pacific Pneumococcal Vaccines Market Revenue (USD billion) Forecast, by Country/Sub-Region, 2021-2034

Table 17: Latin America Pneumococcal Vaccines Market Revenue (USD billion) Forecast, by Product Type, 2021–2034

Table 18: Latin America Pneumococcal Vaccines Market Revenue (USD billion) Forecast, by Age Group, 2021–2034

Table 19: Latin America Pneumococcal Vaccines Market Revenue (USD billion) Forecast, by Distribution Channel, 2021–2034

Table 20: Latin America Pneumococcal Vaccines Market Revenue (USD billion) Forecast, by Country/Sub-Region, 2021-2034

Table 21: Middle East & Africa Pneumococcal Vaccines Market Revenue (USD billion) Forecast, by Product Type, 2021–2034

Table 22: Middle East & Africa Pneumococcal Vaccines Market Revenue (USD billion) Forecast, by Age Group, 2021–2034

Table 23: Middle East & Africa Pneumococcal Vaccines Market Revenue (USD billion) Forecast, by Distribution Channel, 2021–2034

Table 24: Middle East & Africa Pneumococcal Vaccines Market Revenue (USD billion) Forecast, by Country/Sub-Region, 2021-2034

STUDY PERIOD: 2021-2034
BASE YEAR: 2025
HISTORICAL DATA: 2021-2024
NO OF PAGES: 159

Buy Now

Download Free Sample

Security Code

Growth Advisory Services

Clients

Related Reports

Get In Touch With Us

US +1 833 909 2966 ( Toll Free )

UK +44 808 502 0280 ( Toll Free )

+91 744 740 1245 (APAC)
sales@fortunebusinessinsights.com